Anti-EAF1 antibodies are used in the immunodetection of the protein ELL associated factor 1. In humans, the canonical protein has a reported length of 268 amino acid residues and a mass of 29 kDa. Its subcellular localization is in the nucleus. Up to 2 different isoforms have been reported for this protein. It is reported to be highly expressed in the heart, brain, placenta, lung, liver, skeletal muscle, kidney, pancreas, spleen, prostate, testis, small intestine and colon. A member of the EAF protein family, EAF1 is known to act as a transcriptional transactivator of ELL and ELL2 elongation activities. Synonyms for this target antigen include ELL (eleven nineteen lysine-rich leukemia gene)-associated factor 1. EAF1 gene orthologs have been reported in the mouse, rat, bovine, frog, zebrafish, chimpanzee and chicken species. A number of EAF1 antibodies have been mentioned in research publications and have associated citations. Western Blot is a widely used application for these antibodies. In addition, ELISA is also a common application.